Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN112824422B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112824422B discloses a novel chiral ligand enabling high TON asymmetric hydrogenation for pharma intermediates with simplified synthesis.